Lv5
1510 积分 2023-10-19 加入
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
1个月前
已完结
Long-Acting Factor XI Inhibition and Periprocedural Bleeding
1个月前
已完结
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial
1个月前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
1个月前
已完结
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
2个月前
已完结
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
2个月前
已完结
Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
2个月前
已完结
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial
2个月前
已完结
Apixaban and dalteparin in active malignancy associated venous thromboembolism
2个月前
已完结
Low molecular weight heparin for the prevention of deep venous thrombosis after total knee arthroplasty: A systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
